Gamma Medica Raises $11.5M in Financing

Gamma Medica, a Salem, NH-based developer of advanced digital molecular imaging technologies, raised $11.5m in financing.

It included $6.5m in growth capital financing facility from specialty finance company Hercules Technology Growth Capital (NYSE: HTGC) and $5.0m from existing investor Psilos Group.

The company intends to use the funds to increase sales and marketing efforts and grow adoption of Molecular Breast Imaging (MBI) on a global scale.

Led by Jim Calandra, President and CEO, Gamma Medica develops advanced digital imaging technologies for the early detection of breast cancer. The company’s LumaGEM┬« Digital MBI system is a commercially available, dual head, fully solid-state digital imaging system utilizing cadmium zinc telluride (CZT) technology for molecular breast imaging.
It is currently in use at premier hospitals and breast centers throughout the U.S.



Join the discussion